Several pharmaceutical companies are actively pursuing GLP-1 based therapies for alcohol use disorder (AUD), signalling a growing interest in expanding their use beyond metabolic conditions
Retatrutide: The Leading Triple Agonist Retatrutide is the most advanced triple-agonist medication currently in clinical development
The result is a profound Wegovy appetite suppression that silences the food noise and restores a sense of control
Unlike oral supplements, which allow only about 20% of the supplement to be absorbed, we ensure youll feel the effects faster, and enjoy long-lasting benefits
(PubMed) Moura FA, de Andrade KQ, dos Santos JC, Goulart MO
Each vial is labeled with lot-specific tracking to guarantee traceability and reproducibility